• Genotyping Kit for Target Alleles: Precision DNA Prep for Re

  2026-07-26

  Discover how the Genotyping Kit for target alleles of insects, tissues, fishes and cells revolutionizes PCR workflows. This article explores advanced DNA preparation strategies, unique assay decision-making, and unpacks new scientific insights for molecular biology genotyping research.

• Octenidine Dihydrochloride: Applied Antimicrobial Workflows

  2026-07-25

  Octenidine dihydrochloride acts as a high-purity, broad-spectrum antiseptic research compound, enabling robust membrane-disruption assays and next-level protocol optimization. Explore its use in antimicrobial research, actionable workflow enhancements, and troubleshooting strategies built on the latest advances in gemini QAC chemistry.

• HyperScribe T7 High Yield Cy3 RNA Labeling Kit: Optimizing R

  2026-07-24

  The HyperScribe T7 High Yield Cy3 RNA Labeling Kit empowers researchers to generate high-yield, fluorescent RNA probes with flexible labeling and superior sensitivity. Its streamlined workflow and tunable Cy3-UTP incorporation make it ideal for advanced applications such as in situ hybridization and gene regulatory studies.

• Rhodamine 123 (chloride): Precision Tools for Membrane Trans

  2026-07-24

  Rhodamine 123 (chloride) empowers real-time, quantitative analysis of membrane transporter activity, especially for P-glycoprotein and OATP1A2 research. Discover how optimized workflows and troubleshooting strategies with APExBIO's dye can unlock robust, reproducible results in multidrug resistance and transporter function studies.

• Quizartinib (AC220): Applied FLT3 Inhibition Workflows in AM

  2026-07-23

  Quizartinib (AC220) delivers benchmark selectivity and potency for dissecting FLT3-driven mechanisms in acute myeloid leukemia (AML) models. This guide translates high-impact studies into actionable protocols, workflow optimizations, and troubleshooting strategies for reliable, reproducible results.

• Neuroligin 1 Loss in Striatal D2-MSNs Drives Repetitive Beha

  2026-07-23

  This study demonstrates that Neuroligin 1 (NLGN1) deficiency in striatal D2 receptor-expressing medium spiny neurons (D2-MSNs) leads to their hyperactivation and drives repetitive behavioral phenotypes associated with autism spectrum disorder (ASD). By integrating single-nucleus RNA sequencing and functional assays, the research identifies PKC overactivation as a mechanistic link, refining our understanding of the neural circuits underlying restricted and repetitive behaviors.

• MHY1485: Unlocking mTOR Activation for Translational Discove

  2026-07-22

  This article delivers a thought-leadership perspective on leveraging MHY1485 as a precision mTOR activator to elucidate the complex interplay between autophagy, cell proliferation, and disease progression. By integrating mechanistic insights from recent studies—including the EBV–mTORC1–GCNT3 axis in nasopharyngeal carcinoma—we provide strategic guidance for translational researchers seeking to design impactful experiments and accelerate bench-to-bedside innovation.

• Tacrine Hydrochloride Hydrate: Driving Next-Gen Alzheimer’s

  2026-07-22

  Tacrine hydrochloride hydrate (Tetrahydroaminacrine) empowers Alzheimer's disease research with robust enzyme inhibition, neuroprotection modeling, and versatile assay performance. This guide delivers actionable workflows, troubleshooting insights, and cross-validated parameters to maximize reproducibility in neurodegenerative disease research.

• Dual-Action Kinase Inhibitors Accelerate p38α Dephosphorylat

  2026-07-21

  This study uncovers how select kinase inhibitors, by stabilizing specific inactive conformations of p38α MAP kinase, promote its dephosphorylation by phosphatases. The findings suggest a new strategy for designing kinase inhibitors with enhanced specificity and dual-action potential, shifting current approaches in kinase-targeted research.

• Sulfo-NHS-SS-Biotin: Advancing Precision in Cell Surface Pro

  2026-07-21

  Explore how Sulfo-NHS-SS-Biotin empowers translational researchers to precisely map, profile, and purify cell surface proteins—addressing unmet needs in oncology and immunotherapy. This article synthesizes mechanistic insights, protocol best practices, and strategic guidance, critically referencing breakthrough evidence from Nature Biotechnology and situating APExBIO's reagent at the forefront of translational science.

• LMO2-LDB1 Complex Drives AML Progression: Mechanistic Insigh

  2026-07-20

  This article reviews recent research exploring how the LMO2 transcription factor, through its interaction with co-regulator LDB1, promotes acute myeloid leukemia (AML) development. The study uncovers the mechanistic importance of the LMO2/LDB1 complex in leukemic cell proliferation and highlights its potential as a therapeutic target.

• 4-Ethylphenyl Sulfate in Gut-Brain and Renal Biomarker Resea

  2026-07-20

  4-Ethylphenyl sulfate stands out as a robust research tool bridging gut microbiota-brain interaction and renal dysfunction biomarker discovery. Its well-characterized serum dynamics and unique adsorption behaviors provide actionable insights for both neurobehavioral and nephrology workflows.

• 20-HETE–TRPV1–MrgprA3+ Neuron Axis Drives Itch in Dermatitis

  2026-07-19

  This study uncovers how elevated 20-HETE activates TRPV1 channels on MrgprA3+ sensory neurons, leading to heightened itch responses in chronic dermatitis models. By dissecting the molecular crosstalk between pain and itch, the research highlights new potential intervention points for chronic skin inflammation.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Lab G

  2026-07-18

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) prevents unwanted protein degradation during extraction and downstream analysis, especially when divalent cation-sensitive assays are required. It is not suitable for workflows where EDTA-mediated metalloprotease inhibition is essential.

• ERK1/2 Activation by Psoralen Drives Estrogenic Cholestasis

  2026-07-17

  This study elucidates how psoralen and isopsoralen, two phytoestrogenic compounds from Psoraleae Fructus, induce cholestatic liver injury via ERK1/2 pathway activation in zebrafish larvae. The findings identify ERK1/2 as a mechanistic bridge between estrogen-like natural products and impaired bile acid homeostasis, highlighting a potential therapeutic target for estrogen-induced cholestasis.

450 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page